aadvani

I remember reading studies of 30-36 lbs in a year, IF they maintain diet and exercise. I see this adherence as your competitive advantage.

A lot of docs I know are prescribing GLP1s already for weight loss, off label. When they get RCT data, get coverage, you guys will be way ahead. Congrats, amazing concept.

We’re building this for clinical papers! inpharmd.com We have 10k summarized so far

Yep we do! We started building custom but just went into app orchard

Yes, but most don’t seem to mind. There are so many other high ROI things for clinical pharmacists to do instead. Most want to round more or spend more time with patients instead .

Yes! I think every doc probably has a bit of PTSD from EMR rollouts, so probably much harder to find early adopters for any new tech .

Thank you :-) Now we must execute

The clinical pharmacist has so much to do, they’re like Swiss Army knives. Systems that take us on don’t fire anyone to do so; this just frees up their clinical folks to do more patient care duties. So, yes, we want to grow through them !

That’s great! This is the future.

During vaccines, how have your pharmacists managed to do both? I’m sure it’s a lot on them

Yes! But shouldn’t it be central? There are hundreds of thousands of clinical pharmacists answering similar questions every day. To your point- everyone asks unique questions so still get unique answers that they can then combine with patient- specific preferences to make personal decisions.

Am I answering what you asked ? Sorry if not!

Took me a sec too- just replace the www with https://

Clinical pharmacists at every hospital have been key. Many docs prefer to still rely on their clinical pharmacist, which is fine because they (the clinical pharmacists) end up relying on us. Over time, it’s become simpler for many docs to just ask us themselves.

Also, a newsfeed with common/ interesting questions has really helped since the experience gets better with more users.

Excellent questions and thank you for the kind words :-)

1. We tested this with Pfizer last year and found there was an opportunity to supplement existing med info teams that do the same thing.

But it’s tough to do two markets well at once, so we decided to focus on health systems for now.

We also find that in hospitals, everyone thinks they’re asking b unique questions, but they aren’t. We can be much cheaper vs their pharmacists and still make money. Pharma companies already have standard responses so it’s a totally different value prop.

2. We don’t really compete with clinical folks at hospitals, most will readily off load this to us, so they can spend more time on patient care. There are some that like to own this, and I totally get why, but we eventually win them over. As for medical librarians, they’re great for article requests but for complex clinical questions we think a clinical pharmacist is the right type of researcher.

Thank you! This is exactly the type of question we’re here for.

You can create a free trial account here and ask your question, all in 30 sec: https://www.inpharmd.com/provider_signup/new

Then if you like it, pester away!

Same problem, for sure, but we’re taking a different approach.

A SAAS tool has a hard time with complex questions because healthcare data is messy and results will be imperfect.

Therefore we feel strongly about building a human - lead service thats optimized by software.

Every health system employs clinical pharmacists to manually do this today, so we use that as our stake in the ground, and so far we’re finding we’re way more efficient.

Yep, totally. But they have X credible authors so can only have X credible info on their site.

This means they focus on the most common questions.

Public data/ our data shows point of care references like UTD can only answer ~1/2 of clinical questions.

We’re building our tool for the other 1/2.

Great info, and a shame there’s not better real world evidence for cases like this. And I hear you, just making the point that most shouldn't be considered “typical”; we should question everything.

This makes our day :-) Academic MCs are our main target right now. Thank you!

This is gold, thank you.

He went after the same problem, yes, but with a traditional SAAS approach.

We feel strongly that the only way to make this work is to have humans on our back end, thoughtfully automated with tech (vs the other way around).

Despite their best efforts, up to date can never truly be up to date, can they?

No shade, we love up to date; we just see ourselves as a complement.

My bad, typo- meant 6mg here

For anyone curious , we actually did this question:

https://www.inpharmd.com/is-there-any-data-to-support-higher...

Also, we actually did this one, if you’re curious:

https://www.inpharmd.com/is-there-any-data-to-support-higher...

Thanks for the correction I actually typed 6 every 24 but found it confusing and resulted in error, fixed now

We started with a for us, by us approach to build our content and a brand first.

The reason every patient knows of the Physicians Desk Reference is because they believe their doc relies on the PDR.

In just 10 years I’ve seen the doctor go from being the top of the patient care hierarchy to the patient on top (not coincidentally DTC ads have blown up). We think there are a lot like you, and soon, we’ll make our tool publicly available.

If you want to test before that time- reach out! Ashish at InpharmD dot com

This is our hope :-)

Haha good point

When Sherlock is older we may let him go by his middle name

Thanks so much! Hearing we saved you time is our favorite type of feedback!

Off label questions (questions outside the FDA approved indications of a drug) are fun for us. There are so many great ones and this is where the traditional references fall short.

We just have to be fair and balanced about how we present (which we are anyway) + be extra vigilant to include all relevant prescribing info, and especially the actual indications and any boxed warnings.

As for hiring, yes, and for anyone interested, I firmly believe interest in what we’re building is the most important thing at this point, and everything else is secondary. Ashish at InpharmD dot com

Sorry it didn’t land with you. We’re constantly torn between writing for the one person (a healthcare provider) vs a larger population.

An example question is a fantastic idea and will land with both audiences :-)

We’ll get our top three most recent on the homepage ASAP but in the meantime:

If you have a typical late stage COVID patient, a static patient resource like you described is perfectly fine to look at efficacy of the standard dexamethasone 6mg treatment.

But if you have an atypical patient and considering a 20mg dose, you’re out of luck. Most patients are atypical and we see an unmet need with a long tail of atypical questions.

I can understand this take, many docs don’t like to ask questions at all.

But there’s a new school type of doc that realizes how vast the medical literature is (20m studies), how quickly it’s changing (20,000 just added on COVID), and has tons of questions.

All medical references were essentially converted to SAAS products from large books- so they’re thousands of pages covering the mainstream topics, and they answer only ~1/2 of questions.

Health systems employ clinical pharmacists to answer the other 1/2 with evidence because it’s insanely high ROI for them to do so (5M/ pharmacist/ year/ hospital). Health systems outsource this to us because we’re more efficient.